Grant: Discovery Grants Program - Individual
University of Guelph
$26,000.00
Examination of the regulation of the leukotoxin operon in Mannheimia haemolytica.
FY 2014-15
Summary
Mannheimia haemolytica is a Gram negative bacterium and a commensal microorganism in the nasal pharyngeal passage of cattle. When the animals are stressed or suffer from concurrent viral infections, their immune systems are compromised and can not clear the bacterium inhaled into the lungs. The bacterium is able to adhere/colonize the lungs, evade the immune clearance and cause pneumonia due to destruction of the lung tissue. One of the major virulence factor produced by the bacterium is a leukotoxin which targets the bovine leukocytes. The leukotoxin lyses the bovine macrophages to prevent them from attacking the invading bacterium. Lysis of the macrophages release cellular lytic components that leads to destruction of the lung tissue and the loss of lung function. The leukotoxin is a member of the RTX family of cytolysins found in many bacterial pathogens. Even though the genes that code for the leukotoxin have been characterized for over 25 years, very little is known about their regulation of expression. To gain a better understanding on how and when the bacterium decides to produce the leukotoxin, I proposed to investigate the genetic mechanism that regulate expression of the leukotoxin genes. This will be accomplished by mutagenesis experiments and the isolation of non-haemolytic mutants. This genetic screen utilized the haemolytic activity of the leukotoxin which produces a zone of clearance around the bacterial colony on sheep's blood agar plates. The non-haemolytic mutant could be defective in the actual leukotoxin genes, or in another 'factor' required for expression of the leukotoxin genes. After sorting out the mutant into the above two groups, those with mutations not in the leukotoxin genes will be further characterized by complementation with a genomic library to screen for restoration of the haemolytic phenotype. Any recombinant plasmid that can restore the haemolytic phenotype should contain the missing or mutated function. This should identify any novel factor required for expression of the leukotoxin genes. The results from this study could be extended to the regulation of expression of RTX genes in other bacterial pathogens.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
246-2012
Name nom
Lo, Reggie
Department département
Molecular and Cellular Biology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2012
Award amount
26000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5200
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Microbiology
Research subject fr
Microbiologie
Partie
3
Nb partie
5
Application title
Examination of the regulation of the leukotoxin operon in Mannheimia haemolytica.
Keyword
NSERC
Application summary
Mannheimia haemolytica is a Gram negative bacterium and a commensal microorganism in the nasal pharyngeal passage of cattle. When the animals are stressed or suffer from concurrent viral infections, their immune systems are compromised and can not clear the bacterium inhaled into the lungs. The bacterium is able to adhere/colonize the lungs, evade the immune clearance and cause pneumonia due to destruction of the lung tissue. One of the major virulence factor produced by the bacterium is a leukotoxin which targets the bovine leukocytes. The leukotoxin lyses the bovine macrophages to prevent them from attacking the invading bacterium. Lysis of the macrophages release cellular lytic components that leads to destruction of the lung tissue and the loss of lung function. The leukotoxin is a member of the RTX family of cytolysins found in many bacterial pathogens. Even though the genes that code for the leukotoxin have been characterized for over 25 years, very little is known about their regulation of expression. To gain a better understanding on how and when the bacterium decides to produce the leukotoxin, I proposed to investigate the genetic mechanism that regulate expression of the leukotoxin genes. This will be accomplished by mutagenesis experiments and the isolation of non-haemolytic mutants. This genetic screen utilized the haemolytic activity of the leukotoxin which produces a zone of clearance around the bacterial colony on sheep's blood agar plates. The non-haemolytic mutant could be defective in the actual leukotoxin genes, or in another 'factor' required for expression of the leukotoxin genes. After sorting out the mutant into the above two groups, those with mutations not in the leukotoxin genes will be further characterized by complementation with a genomic library to screen for restoration of the haemolytic phenotype. Any recombinant plasmid that can restore the haemolytic phenotype should contain the missing or mutated function. This should identify any novel factor required for expression of the leukotoxin genes. The results from this study could be extended to the regulation of expression of RTX genes in other bacterial pathogens.